A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade

NCT04124094 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence

Interventions

DRUG: Test Product (Fluticasone propionate and salmeterol xinafoate inhalation powder/Respirent Pharmaceuticals)
DRUG: Reference Product (SERETIDE DISKUS® 100/50 inhalation powder/GSK)
OTHER: Activated Charcoal suspension

Sponsor

Respirent Pharmaceuticals Co Ltd.

Collaborators

[object Object]